INTRODUCTION
Congenital isolated ACTH deficiency (IAD) à low plasma ACTH and serum cortisol with preserved function of all other pituitary hormones.
CLINICAL CASE
We report a neonate of Romanian origin, who presented at 15 hours of life with respiratory arrest and hypoglycaemia. Over the following 2 weeks recurrent hypoglycaemia was documented.
On examination à normal male genitalia and no hyperpigmentation Biochemical investigations: à Undetectable serum cortisol (cortisol <1 μg/dl; NR 7.8-26.2) and à Inappropriate plasma ACTH levels (22.1 pg/ml; NR 4.7-48.8) He responded to hydrocortisone treatment and continues on replacement. He has a healthy sister who is 30 months older. However, there is a family history of adrenal disease as his aunt (mother's sister) has been on hydrocortisone treatment since 18 months of age with a diagnosis of suspected IAD. A novel, homozygous, extremely rare, synonymous variant p.Thr96= was found in exon 2 of the TBX19 gene ( Figure 3 ; Table 1 ).
TBX19 is a T-box transcription factor involved in the terminal differentiation of pituitary POMC expressing cells (Figure 1 The effect of the novel mutation was assessed by an in vitro splicing assay, pET01 ExonTrap cloning vector (MobiTec), comparing wild type and mutant heterologous minigenes. We have identified a translationally silent TBX19 mutation causing aberrant splicing as the likely cause of isolated ACTH deficiency in the patient. Most mRNA transcripts are aberrantly spliced leading to a truncated, non-functional protein in keeping with the complete loss of cortisol production and early presentation in the patient. 
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